#Colonoscopy Devices Market Analysis | Explore Tumblr posts and blogs

cmipooja · 1 year ago

Text

Global Colonoscopy Devices Market Is Estimated To Witness High Growth Owing To Increasing Adoption of Minimally Invasive Procedures

The global Colonoscopy Devices Market is estimated to be valued at US$2,375.9 million in 2022 and is expected to exhibit a CAGR of 5.2% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: Colonoscopy devices are used for the diagnosis and treatment of various gastrointestinal disorders. These devices allow physicians to examine the inner lining of the colon and rectum. The advantages of using colonoscopy devices include early detection of colorectal cancer, removal of polyps, and diagnosis of various gastrointestinal conditions. The increasing prevalence of colorectal cancer and gastrointestinal disorders is driving the demand for colonoscopy devices. The need for accurate and early diagnosis is also fueling market growth. Market Key Trends: One key trend in the global colonoscopy devices market is the increasing adoption of minimally invasive procedures. Minimally invasive procedures offer several advantages over traditional open surgeries, such as reduced pain, shorter recovery time, and minimal scarring. This trend is driven by the growing patient preference for less invasive treatments and advancements in technology that support minimally invasive procedures. For example, the development of advanced imaging systems and robotic-assisted surgeries has led to more precise and efficient colonoscopies. PEST Analysis: - Political: Government initiatives and policies promoting colorectal cancer screening programs drive market growth. - Economic: Increasing healthcare expenditure and insurance coverage for colonoscopy procedures contribute to market expansion. - Social: Growing awareness about the importance of early detection and prevention of colorectal cancer boosts market demand. - Technological: Advancements in imaging technology and robotic-assisted surgeries have improved the accuracy and efficiency of colonoscopies. Key Takeaways: 1: The Global Colonoscopy Devices Market Size is expected to witness high growth, exhibiting a CAGR of 5.2% over the forecast period, due to increasing adoption of minimally invasive procedures. Minimally invasive procedures offer advantages such as reduced pain and faster recovery, driving market demand. 2: In terms of regional analysis, North America is the fastest-growing and dominating region in the global colonoscopy devices market. This can be attributed to the high prevalence of colorectal cancer, well-established healthcare infrastructure, and favorable reimbursement policies. Europe is also a significant market, supported by increasing awareness and government initiatives for colorectal cancer screening. 3: Key players operating in the global colonoscopy devices market include Karl Storz SE & Co. KG, Olympus Corporation, Endo Med Systems GmbH, HOYA Corporation, Getinge AB, Avantis Medical Systems, Boston Scientific Corporation, and FUJIFILM Holdings Corporation. These companies focus on product innovations, strategic collaborations, and mergers and acquisitions to enhance their market presence. In conclusion, the global colonoscopy devices market is poised for significant growth due to the increasing adoption of minimally invasive procedures. Factors such as the rising prevalence of colorectal cancer and gastrointestinal disorders, along with technological advancements, are driving market demand. North America and Europe are the key regions driving market growth. Key players in the market continue to innovate and collaborate to expand their product portfolios and gain a competitive edge.

#Colonoscopy Devices Market #Colonoscopy Devices Market Insights #Colonoscopy Devices Market Forecast #Colonoscopy Devices Market Analysis #Colonoscopy Devices #Colonoscopy Devices Market Outlook #Colonoscopy #Medical Devices #gastrointestinal diseases #colon cancer #colorectal cancer #colonoscopies #Coherent Market Insights

0 notes

farmacuticals · 18 days ago

Text

Exploring the Future of the Colonoscope Market: Emerging Trends and Forecasts

A colonoscope is a specialized, flexible instrument used by medical professionals to examine the inner lining of the colon and rectum. This examination, known as a colonoscopy, is primarily used to detect abnormalities such as polyps, inflammation, or early signs of cancer. The colonoscope is typically equipped with a small camera at the end, which transmits high-resolution images to a screen, allowing the physician to inspect the colon's interior in real-time. Colonoscopies are recommended for people over the age of 50 as part of routine screening, as well as for individuals with a family history of colorectal issues or other risk factors.

The expected size of the colonoscope market in 2022, according to MRFR analysis, was 3.28 (USD billion). By 2032, the colonoscope market is projected to have grown from 3.4 billion US dollars in 2023 to 4.64 billion US dollars. During the forecast period (2024-2032), the colonoscope market's compound annual growth rate (CAGR) is anticipated to be approximately 3.52%.

Size Colonoscope

The "Size Colonoscope" is an essential consideration in this procedure because it determines the comfort and effectiveness of the examination. Colonoscopes come in various lengths and diameters, typically ranging from 100 cm to 160 cm, and are chosen based on the patient's size, anatomy, and the specific purpose of the examination. Pediatric colonoscopes are generally shorter and have a smaller diameter, allowing for comfortable use in younger patients or adults with narrow anatomies. In contrast, standard colonoscopes are used in most adult examinations. Advanced colonoscopes may feature a wider diameter to accommodate additional instruments for biopsies or polyp removal, ensuring a thorough and precise inspection.

Colonoscope Share

The market for colonoscope share has been growing due to rising awareness about preventive healthcare, increasing incidences of colorectal cancer, and improvements in colonoscopy technology. The global demand for colonoscopes is expected to rise steadily as more healthcare providers adopt these devices for early detection of gastrointestinal diseases. Colonoscope share includes various manufacturers and suppliers who provide a range of colonoscopy instruments, each contributing to the sector's overall growth. Leading companies, hospitals, and clinics rely on colonoscopes from trusted brands to ensure high-quality imaging and reliable results, further driving market expansion.

Colonoscope Analysis

Conducting a thorough colonoscope analysis helps stakeholders understand current trends, usage patterns, and technological advancements in the colonoscopy field. Through colonoscope analysis, manufacturers and healthcare facilities can gain insights into the performance, safety, and durability of various models. This analysis also aids in identifying areas for improvement, such as enhancing the flexibility of the device, improving image quality, and reducing patient discomfort. Additionally, analyzing colonoscope data helps in predicting future trends and adapting to the changing demands of the healthcare industry.

Central Fill Pharmacy Automation System Trends

The central fill pharmacy automation system is an evolving trend that complements the colonoscopy field by streamlining medication management and delivery. Central fill pharmacy automation systems improve operational efficiency in healthcare facilities, enabling pharmacists to automate prescription processing and reduce medication errors. The trend toward automating pharmacy systems is gaining traction due to its ability to increase accuracy and save time. With central fill pharmacy automation system trends on the rise, pharmacies are now able to meet the growing demands of patients in a timely and efficient manner, supporting better healthcare delivery in conjunction with other diagnostic tools like the colonoscope.

Reasons to Buy the Reports

Comprehensive Market Insights: The reports offer a detailed analysis of the colonoscope industry, including market share, size, and recent trends, helping buyers make informed decisions.

Technological Advancements: Understand the latest technology and innovation trends shaping the colonoscope industry and how they impact end-user experience.

Competitive Landscape: Gain knowledge on key players, their strategies, and their market positioning, allowing for strategic planning.

Investment Opportunities: Identify areas for potential investment within the colonoscope market and capitalize on future growth prospects.

Regulatory Insights: Get up-to-date information on the regulatory landscape, which influences product approval, quality standards, and market entry.

Recent Developments

Recent advancements in colonoscope technology have focused on improving patient comfort, visualization quality, and diagnostic accuracy. Some new colonoscopes now incorporate high-definition imaging with better flexibility, making it easier for physicians to navigate through the colon. Other developments include the use of AI-enhanced colonoscopes that can detect polyps more efficiently. Additionally, the integration of 3D imaging and enhanced light sources offers a clearer view, aiding in early detection of colorectal diseases. These innovations continue to push the boundaries of diagnostic technology, making colonoscopes an increasingly vital tool in preventive healthcare.

Related reports:

cellular nutrition market

cleaning chemicals healthcare market

dental contouring market

Top of Form

Bottom of Form

0 notes

poonamcmi · 3 months ago

Text

Colorectal Cancer Screening Market Primed for Growth due to Rising Disease Prevalence

The colorectal cancer screening market involves various procedures and diagnostic tests for early detection and prevention of colorectal cancer. Some common screening methods include fecal occult blood tests, flexible sigmoidoscopy, double-contrast barium enema, and colonoscopy. Colorectal cancer screening helps detect precancerous polyps or early stage cancer that can often be treated successfully. It also aids in lowering the incidence and mortality of this preventable disease.

The global colorectal cancer screening market is estimated to be valued at US$ 15.44 Bn in 2024 and is expected to exhibit a CAGR of 7.1% over the forecast period 2024 to 2031.

Key Takeaways

Key players operating in the colorectal cancer screening market are Polymedco Inc., Eiken Chemical Co. Ltd., Sysmex Corporation, Siemens Healthineers AG, Quidel Corporation, Novigenix SA, Hemosure Inc., Exact Sciences Corp., Epigenomics Inc., Olympus Corporation, Clinical Genomics Technologies Pty Ltd., Exact Sciences Corporation, Clinical Genomics, Guardant Health, Inc., Hemosure Inc., and Geneoscopy, Inc. These players are focused on launching advanced and easy-to-use screening tests to expand their presence.

The Colorectal Cancer Screening Market Size for players to leverage the growing awareness about early detection and increase screening rates in developing countries. Companies are engaging in partnerships and collaborations to penetrate developing markets and make screening accessible to a wider population.

Globally, there is an increasing focus on population-based screening programs to reduce the burden of colorectal cancer. Several regions have implemented organized screening programs through healthcare facilities. Meanwhile, growing pilot programs in Asian and Latin American countries indicate the potential for market expansion. Market Drivers

The rapid rise in colorectal cancer incidence worldwide due to lifestyle changes, obesity, and Colorectal Cancer Screening Market Size And Trends It is estimated that the number of new cases diagnosed each year will increase by 60% by 2030. Growing disease prevalence enhances the need for widespread screening practices to detect cancer at treatable stages. Additionally, increasing reimbursement for FDA-approved screening tests, favorable government initiatives, and rising awareness about early detection are supporting the adoption of screening worldwide. PEST Analysis Political: Government regulations and healthcare reforms impact the adoption of colorectal cancer screening tests. Favorable reimbursement policies can boost the market growth. Economic: Rising healthcare expenditures and growing disposable incomes encourage people to opt for preventive healthcare check-ups including colorectal cancer screening tests. Social: Increasing awareness about early detection benefits, changing lifestyles, and growing geriatric population drive the demand for colorectal cancer screening. Technological: Advancements in biopsy techniques, endoscopy devices, diagnostic platforms enable detection of colorectal cancer at an early stage. Novel non-invasive tests based on blood, stool and CSF analysis are gaining traction.

Colorectal cancer screening market in terms of value is highly concentrated in developed regions like North America and Western Europe due to established healthcare infrastructure and widespread awareness. The United States dominates the market owing to favorable reimbursement policies and regular screening recommendations.

Asia Pacific is recognized as the fastest growing regional market for colorectal cancer screening attributed to rising healthcare spending, growing number of screening programs, and increasing incidence of colorectal cancer cases especially in China, Japan and India. Improving diagnostic capabilities and economic development are expected to boost early detection in Asia Pacific over the forecast period. Get More Insights On, Colorectal Cancer Screening Market About Author: Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemical and materials, defense and aerospace, consumer goods, etc. (https://www.linkedin.com/in/money-singh-590844163

#Colorectal Cancer Screening Market Size #Colorectal Cancer Screening Market Tremds #Colorectal Cancer Screening Market Demand #Colorectal Cancer Screening #Colorectal Cancer Screening Market

0 notes

credenceresearchdotblog · 3 months ago

Text

The global demand for Calprotectin testings was valued at USD 195.8 Billion in 2022 and is expected to reach USD 290.5 Billion in 2030, growing at a CAGR of 5.80% between 2023 and 2030. Calprotectin testing has emerged as a crucial diagnostic tool in the medical field, particularly in the detection and management of inflammatory bowel diseases (IBD) such as Crohn's disease and ulcerative colitis. This article provides an in-depth analysis of the calprotectin testing market, exploring its growth drivers, market dynamics, challenges, and future prospects.

Browse the full report at https://www.credenceresearch.com/report/calprotectin-testing-market

Understanding Calprotectin Testing

Calprotectin is a protein found in neutrophils, a type of white blood cell. When inflammation occurs in the gastrointestinal (GI) tract, neutrophils release calprotectin into the stool. Elevated levels of calprotectin in feces indicate inflammation in the intestines, making it a valuable biomarker for diagnosing and monitoring IBD. The non-invasive nature of fecal calprotectin testing has made it an attractive alternative to more invasive procedures like colonoscopy, particularly for initial screenings and ongoing disease management.

Market Growth Drivers

1. Rising Prevalence of IBD and GI Disorders: The increasing incidence of IBD and other gastrointestinal disorders is one of the primary drivers of the calprotectin testing market. According to the Crohn's & Colitis Foundation, approximately 1.6 million Americans are affected by IBD, with numbers rising globally. The need for accurate and non-invasive diagnostic tools has become paramount, leading to the widespread adoption of calprotectin testing.

2. Shift Toward Non-Invasive Diagnostic Methods: Patients and healthcare providers are increasingly favoring non-invasive diagnostic techniques due to their ease of use, reduced discomfort, and lower risk of complications. Fecal calprotectin testing fits this trend, offering a reliable method to assess intestinal inflammation without the need for invasive procedures.

3. Technological Advancements: Advances in diagnostic technology have significantly improved the accuracy, sensitivity, and specificity of calprotectin tests. Automated testing platforms, point-of-care devices, and the development of home testing kits are making calprotectin testing more accessible and convenient, driving market growth.

4. Increased Awareness and Early Diagnosis: Growing awareness about the importance of early diagnosis and monitoring of IBD has led to a rise in calprotectin testing. Early detection of inflammation can help in timely intervention, improving patient outcomes and reducing healthcare costs.

Market Challenges

Despite its advantages, the calprotectin testing market faces certain challenges that may hinder its growth.

1. Cost Constraints: The cost of calprotectin testing, especially in regions with limited healthcare budgets, can be a barrier to widespread adoption. Although the cost is lower than invasive procedures, it may still be prohibitive for some patients, particularly in low-income countries.

2. Limited Availability in Some Regions: While calprotectin testing is widely available in developed countries, access remains limited in many developing regions. Lack of infrastructure, inadequate training for healthcare providers, and limited awareness are some of the factors contributing to this disparity.

3. Competition from Alternative Diagnostic Methods: Although calprotectin testing is non-invasive and reliable, it faces competition from other diagnostic methods, including endoscopy, imaging techniques, and blood tests. These alternatives, particularly in well-equipped healthcare settings, may limit the market's growth potential.

Market Segmentation

The calprotectin testing market can be segmented based on product type, end-user, and region.

1. By Product Type: - Kits and Assays: These are the most commonly used products in calprotectin testing, offering a range of options for laboratory and point-of-care testing. - Instruments: Automated platforms and analyzers are used to process calprotectin tests in clinical laboratories.

2. By End-User: - Hospitals and Clinics: These are the primary users of calprotectin tests, particularly in diagnosing and monitoring IBD patients. - Diagnostic Laboratories: Independent laboratories play a significant role in calprotectin testing, offering specialized services to healthcare providers. - Home Care: The availability of home testing kits has enabled patients to monitor their condition from the comfort of their homes.

3. By Region: - North America: The largest market, driven by high prevalence of IBD and advanced healthcare infrastructure. - Europe: A significant market with widespread adoption of non-invasive diagnostic tools. - Asia-Pacific: A growing market due to rising awareness and increasing healthcare expenditure. - Latin America and Middle East & Africa: Emerging markets with potential for future growth.

Future Prospects

The future of the calprotectin testing market looks promising, with continued advancements in diagnostic technology and increasing adoption of non-invasive testing methods. The development of more affordable and accessible testing solutions, particularly for emerging markets, will be crucial for sustained growth.

Furthermore, ongoing research into the role of calprotectin in other inflammatory conditions may expand the market beyond IBD, opening up new opportunities for innovation and application.

Key Players

Actim Oy

Calpro AS

BUHLMANN Laboratories AG

EagleBio

Cer Test Biotec S.L

EUROIMMUN Medizinische Labordiagnostika AG

Boditech Med Inc.

Biohit Oyj

American Laboratory Products Company, Ltd.

DIAsource ImmunoAssays S.A

R-Biopharm AG.

Abbexa

AccuBio Tech Co., Ltd.

Hangzhou Biotest Biotech Co., Ltd

Thermo Fisher Scientific

Epitope Diagnostics, Inc

Elabscience Biotechnology Inc

Vitassay Healthcare, S.L.U.

Beckman Coulter Inc.

Diasorin

Segmentation

By Test Kits

Calprotectin ELISA Test Kits

Calprotectin Rapid Testing Kits

By Indication

Stool

Blood Serum/Plasma

Other Biological Indications

By Indication

Irritable Bowel Syndrome

Ulcerative Colitis

Crohn’s Disease

Colorectal Cancer

By End User

Hospitals

Diagnostic Laboratories

Specialty Clinics

North America

Canada

Mexico

Europe

Germany

France

Italy

Spain

Rest of Europe

Asia Pacific

China

Japan

India

South Korea

South-east Asia

Rest of Asia Pacific

Latin America

Brazil

Argentina

Rest of Latin America

Middle East & Africa

GCC Countries

South Africa

Rest of Middle East and Africa

Browse the full report at https://www.credenceresearch.com/report/calprotectin-testing-market

About Us:

Credence Research is committed to employee well-being and productivity. Following the COVID-19 pandemic, we have implemented a permanent work-from-home policy for all employees.

Contact:

Credence Research

Please contact us at +91 6232 49 3207

Email: [email protected]

Website: www.credenceresearch.com

0 notes

trendingreportz · 4 months ago

Text

Cancer Testing Screening Market - Forecast(2024 - 2030)

Cancer Testing Screening Market Overview

Cancer Testing Screening Market size is projected to reach $220.66 billion by 2027 and is expected to grow at a CAGR of 6.4% during the forecast period 2022-2027. Cancer Testing and Screening are vital procedures for aid in the early detection of cancer before symptoms occur. It lowers the risk of malignant cells growing abnormally and lowers the person's mortality rates. Each type of cancer has a screening test that can help spot cancer early on. There is increasing adoption of cancer screening tests, particularly in countries with the highest cancer rates. The improved research and development activities coupled with the increasing public awareness of cancer diseases are all predicted to create a new window of opportunities in the global cancer Testing screening market. However, COVID-19 has restrained the market growth. The lack of adequate supplies needs for more service providers added to the crises, thereby restraining the market growth.

Cancer Testing Screening Market Report Coverage

The report: “Cancer Testing Screening Market Forecast (2022-2027)”, by Industry ARC, covers an in-depth analysis of the following segments of the Cancer Testing Screening Market.

By Type: Diagnostics, Screening. By Cancer Type: Respiratory System Cancer, Leukemia, Myeloma and Lymphoma, Skin Cancer, Abdominal/Digestive System Cancer, Genital Cancer, Oral Cancer, Urinary System Cancer, Endocrine System Cancer, Breast Cancer, Others. By Technique: Imaging, Biopsy, Genomic and Molecular Tests (Next Generation Sequencing, RT-PCR, Microarrays, Biomarker Testing, Others. By Product Type: Molecular Diagnostics, Companion Diagnostics. By Stage: Terminal, Stage 0-4, Prognosis, Other Staging System. By Gender: Male, Female. By Geography: Americas (U.S, Canada, Brazil, Rest of Americas), Europe (U.K, Germany, France, Italy, Spain and Rest of Europe), Asia-Pacific (China, Japan, India, and South Korea), and Rest of the World (Middle East, Africa).

Request Sample

Key Takeaways

Geographically, The Americas Cancer Testing Screening market accounted for the highest revenue share in 2021, followed by Europe. This is owing to the steady rise of Lung and Prostate Cancer cases in both regions which are being driven by the adoption of unhealthy lifestyles such as excessive alcohol consumption and smoking.

The increasing number of cancer cases around the world is unfortunate. However, it is beneficial to the cancer screening industry. The industry is also being propelled forward by Increased research and development (R&D) to develop effective cancer treatments and early detection. Innovative technologies including positron emission mammography, spectroscopy-enhanced colonoscopy, and hyperpolarization MRI, among others, are improving screening efficiency.

Cancer Testing Screening Market Detailed Analysis on the Strength, Weakness, and Opportunities of the prominent players operating in the market will be provided in the Cancer Testing Screening Market report.

Cancer Testing Screening Market Segment Analysis – By Cancer Type

The Cancer Testing Screening Market based on Cancer Type can be segmented into Respiratory System Cancer, Leukemia, Myeloma, and Lymphoma, Skin Cancer, Abdominal/Digestive System Cancer, Genital Cancer, Oral Cancer, Urinary System Cancer, Endocrine System Cancer, Breast Cancer, and Others. Abdominal/Digestive system cancer had the largest share in the cancer testing screening market in 2021 and is expected to grow at a CAGR of 5.9% owing to the rise in consumption of processed food and alcohol. Additionally, the increase in the global geriatric population has generated demand for imaging devices for early detection and treatment of Abdominal cancer, thereby driving the segment. According to the Organization of the United Nations, the proportion of people aged 65 and up in the global population climbed from 6% in 1990 to 9% in 2019. By 2050, that percentage is expected to climb to 16%, implying that one in every six individuals on the planet is predicted to be 65 or older.

Inquiry Before Buying

Cancer Testing Screening Market Segment Analysis – By Technique

The Cancer Testing Screening Market based on the Technique can be segmented into Imaging, Biopsy, Genomic and Molecular Tests (Next Generation Sequencing, RT-PCR, Microarrays, Biomarker Testing, and Others. Biopsy technique dominated the Cancer testing screening Market in 2021 and is expected to grow at a CAGR of 6.2%. This is owing to its high accuracy during Cancer Diagnosis. Other Diagnostic advances, such as imaging techniques, have increased demand for cancer testing and screening. Imaging has become an important aspect of cancer detection and diagnosis, with recent advancements in tumor imaging technologies improving the diagnosis of five common cancers, including breast, lung, prostate, and colorectal cancers.

Cancer Testing Screening Market Segment Analysis – By Geography

The Cancer Testing Screening Market based on Geography can be segmented into Americas, Europe, Asia-Pacific, and the Rest of the World. Americas region dominated the cancer screening/testing market in 2021 with a market share of 41% and is growing at a CAGR of 4.5% during the forecast period 2022-2027. This is owing to the high rate of new cancer cases each year along with increased awareness amongst the masses.

However, Asia Pacific is set to be the fastest-growing segment with a CAGR of 11% during the forecast period 2022-2027. This is owing to the growing rate of endocrine, abdominal, leukemia, myeloma, and lymphoma cancers in the Asia Pacific region.

Schedule a Call

Cancer Testing Screening Market Drivers

Growing Number Of Cancer Screening Awareness Campaigns To Raise Awareness About The Importance Of Early Detection Of Breast Cancer Is To Drive Market Growth

Several governmental and commercial groups are launching various campaigns to raise awareness about the importance of early detection of breast cancer, the second most frequent cancer among women in the United States. Breast Cancer Diagnostics Market Growth Depends on Cancer Awareness Campaigns. Nations around the globe have initiated various Cancer Screening Awareness Campaigns to encourage young people to make these life-saving behaviors part of their daily routine. For example, Breast cancer campaigns, Cervical cancer awareness campaigns, Protect Your Skin campaigns, Ovarian cancer awareness campaigns and Colorectal cancer awareness campaigns are among the few impacting the growth of the cancer screening and diagnostics market. For instance, the 'Be Clear on Cancer campaign has substantially increased the number of referrals under the 2WW rule. This has increased demands on both resources (59% more tests) and finance. Cost per cancer detected rose by 27% with no increase in funding to support the increased activity.

Technological Advancements And Automation In Cancer Testing And Screening Is To Fuel Service Demand

Cancer testing has become more accurate and user-friendly as a result of technological developments and automation, which has aided industry growth. Novel screening technologies have largely been adopted owing to their ability to increase tumor detection rates. Additionally, the cancer testing & screening market is likely to be driven by the approval of novel biomarkers and increased R&D spending. The key players in the market are increasingly investing in AI-based imaging biomarkers. For instance, Brainomix has invested $21.2 million for the development of an AI platform that automates validated imaging biomarkers to improve both diagnosis and treatment decisions to build on the proven success of the company's tech platform in stroke and enable value-generating pharmaceutical partnerships. Proteomics and genomics are two OMICS technologies that will propel the cancer testing & screening industry forward.

Cancer Testing Screening Market Challenges

High Cost Of Cancer Diagnosis And Increased Financial Burden To Hamper The Market Growth

Cancer has a significant financial impact on patients and their families. Today, the estimated 16.1 million cancer patients face annual out-of-pocket medical expenses that are 61% higher than those who do not have cancer. Cancer patients had higher out-of-pocket costs than non-cancer patients, with high-deductible health plans having the greatest out-of-pocket costs. According to a report by the National Coalition of Cancer Survivorship 47% of cancer patients reported financial burden in cancer care.

Buy Now

Cancer Testing Screening Industry Outlook

Product Launch, Collaboration, and Acquisitions key strategies adopted by players in the Cancer Testing Screening Market. In 2020, the Cancer Testing Screening Market share is consolidated by the top ten players present in the market. In the Cancer Testing Screening Market, the top 10 companies are-

DiaSorin S.p.A

Immunodiagnostic Systems Holdings Ltd

Epigenomics AG

Quest Diagnostics Inc.

F. Hoffmann-La Roche Ltd

VolitionRX Limited

Abbott Laboratories

QIAGEN GmbH

Siemens Healthineers AG

Becton, Dickinson, and Company

Recent Developments

In January 2022, Siemens Healthineers, through its subsidiary Varian entered into a ten-year strategic partnership with Oulu University Hospital in Finland, to build a comprehensive digital, diagnostic and therapeutic ecosystem that addresses the entire cancer treatment pathway. Siemens will supply a technology and services package to Oulu University Hospital that includes cancer imaging and radiation therapy equipment, software solutions for enhanced workflow and decision support, and related support services.

In February 2022, Becton, Dickinson, and Company acquired Cytognos, a company specializing in flow cytometry solutions for blood cancer diagnosis, minimal residual disease (MRD) detection, and immune monitoring research for blood diseases. The acquisition enables BD to enhance chronic illness management by increasing its offering of blood cancer diagnostics, immunological assessment tests, and informatics.

In October 2021, Roche entered into a collaboration with PathAI, a global leader in artificial intelligence (AI)-powered technology for pathology. Under the agreement, the companies are to jointly develop an embedded image analysis workflow for pathologists, which can benefit cancer patients through more precise diagnosis.

#Cancer Testing Screening Market #Cancer Testing Screening Market Share #Cancer Testing Screening Market Size #Cancer Testing Screening Market Forecast #Cancer Testing Screening Market Report #Cancer Testing Screening Market Growth

0 notes

ilmemcmi · 4 months ago

Text

Inflation Devices Market is Owing to Rising Prevalence of Chronic Diseases

Inflation devices are medical instruments that are used in various therapeutic and diagnostic procedures such as angioplasty, colonoscopy and endoscopy. They play a crucial role in widening or dilating the internal passages or cavities of the body. Inflation devices help push open blocked or narrowed blood vessels to improve blood flow and relieve pressure and symptoms. These devices help insert or remove medical devices such as stents, catheters or balloons during surgical procedures. Rising prevalence of cardiovascular diseases, gastrointestinal disorders and respiratory diseases has boosted the demand for various minimally invasive surgeries which in turn is propelling the inflation devices market.

The global inflation devices market is estimated to be valued at US$ 5.35 Mn in 2024 and is expected to exhibit a CAGR of 5.9% over the forecast period 2024 to 2031.Key Takeaways Key players operating in the inflation devices market are Bristol-Myers Squibb Co., Bayer AG, Johnson & Johnson Services Inc., Sanofi S.A., Novartis International AG, AstraZeneca plc., Daiichi Sankyo Co Ltd, Boehringer Ingelheim International GmbH, Pfizer Inc., and Merck KGaA. These players are focusing on new product launches, geographical expansions and mergers and acquisitions to strengthen their Inflation Devices Market Growth.

The increasing prevalence of chronic diseases such as cardiovascular diseases, gastrointestinal diseases and obesity has boosted the demand for minimally invasive surgeries worldwide creating significant growth opportunities for players in the inflation devices market.

Key players are expanding their operations in emerging regions of Asia Pacific, Latin America, and Middle East & Africa. Factors such as rising healthcare spending, growing medical tourism, increasing disposable incomes and expanding product portfolios geared towards local requirements are expected to drive the demand for inflation devices in these regions.

Market Drivers

- Rising prevalence of chronic diseases- The increasing incidence of chronic diseases such as cardiovascular diseases, respiratory diseases and gastrointestinal disorders is propelling the demand for therapeutic and diagnostic procedures which require inflation devices.

Market restraints

- Increasing adoption of alternative treatment methods- Alternative treatment methods such as drug therapies and open surgeries are gaining popularity over minimally invasive surgeries reducing the demand for inflation devices in certain therapeutic areas.

- Reimbursement issues- Lack of favorable reimbursement policies for new medical technologies and lack of insurance coverage for minimally invasive procedures in developing nations poses a major challenge for players in the inflation devices market.

Segment Analysis

The Inflation Devices market is dominated by the Disposable Inflation Devices sub segment. Disposable inflation devices are preferred more as they reduce the risk of infection and contamination between patients. Their single use nature ensures sterility which is important in medical procedures. These devices also help avoid the reprocessing costs associated with reusable inflators.

Global Analysis

The North America region holds the largest share in the Inflation Devices market currently. This is owing to factors such as rising prevalence of cardiovascular diseases, growing geriatric population and well developed healthcare system in the region. Availability of advanced medical facilities and reimbursement policies have further boosted the adoption of inflation devices. The Asia Pacific region is expected to grow at the fastest rate during the forecast period. Rising medical tourism industry along with growing healthcare expenditures in developing countries of China and India will drive the demand for inflation devices in the coming years.

Gets More Insights on, Inflation Devices Market

About Author:

Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. (https://www.linkedin.com/in/ravina-pandya-1a3984191)

#Inflation Devices Market Size #Inflation Devices Market Share #Inflation Devices Market Demand

1 note · View note

deshpandeisha · 6 months ago

Text

Robotic Endoscopy Devices Market Size Patterns with Our Research Firm

The global robotic endoscopy devices market size reached USD 1,683.1 Million in 2021 and is expected to register a revenue CAGR of 12.7% during the forecast period, according to latest analysis by Emergen Research.

High demand for endoscopy for diagnosis and treatment of target diseases, in addition to rising investments, grants, and funds by governments and global organizations for healthcare infrastructure improvement, and availability of new products and devices equipped with advanced technologies are some of the key factors driving market revenue growth.

Get Download Pdf Sample Copy of this Report@ https://www.emergenresearch.com/request-sample/1036

Competitive Terrain:

The global Robotic Endoscopy Devices industry is highly consolidated owing to the presence of renowned companies operating across several international and local segments of the market. These players dominate the industry in terms of their strong geographical reach and a large number of production facilities. The companies are intensely competitive against one another and excel in their individual technological capabilities, as well as product development, innovation, and product pricing strategies.

The leading market contenders listed in the report are:

Auris Health, Inc., Olympus Corporation. Intuitive Surgical, Brainlab AG, Asensus Surgical US, Inc., CMR Surgical Ltd., avateramedical GmbH, Medtronic, B. Braun Melsungen AG, Boston Scientific Corporation, and AKTORmed GmbH

Key market aspects studied in the report:

Market Scope: The report explains the scope of various commercial possibilities in the global Robotic Endoscopy Devices market over the upcoming years. The estimated revenue build-up over the forecast years has been included in the report. The report analyzes the key market segments and sub-segments and provides deep insights into the market to assist readers with the formulation of lucrative strategies for business expansion.

Competitive Outlook: The leading companies operating in the Robotic Endoscopy Devices market have been enumerated in this report. This section of the report lays emphasis on the geographical reach and production facilities of these companies. To get ahead of their rivals, the leading players are focusing more on offering products at competitive prices, according to our analysts.

Report Objective: The primary objective of this report is to provide the manufacturers, distributors, suppliers, and buyers engaged in this sector with access to a deeper and improved understanding of the global Robotic Endoscopy Devices market.

Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now)@ https://www.emergenresearch.com/request-discount/1036

Segments Covered in this report are:

Approach Outlook (Revenue, USD Million; 2019-2030)

Surgical

Diagnostic

Application Outlook (Revenue, USD Million; 2019-2030)

Laparoscopy

Colonoscopy

Bronchoscopy

Others

End-Use Outlook (Revenue, USD Million; 2019-2030)

Ambulatory surgical centers

Hospitals

Others

Browse Full Report Description + Research Methodology + Table of Content + Infographics@ https://www.emergenresearch.com/industry-report/robotic-endoscopy-devices-market

Major Geographies Analyzed in the Report:

North America (U.S., Canada)

Europe (U.K., Italy, Germany, France, Rest of EU)

Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)

Latin America (Chile, Brazil, Argentina, Rest of Latin America)

Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

ToC of the report:

Chapter 1: Market overview and scope

Chapter 2: Market outlook

Chapter 3: Impact analysis of COVID-19 pandemic

Chapter 4: Competitive Landscape

Chapter 5: Drivers, Constraints, Opportunities, Limitations

Chapter 6: Key manufacturers of the industry

Chapter 7: Regional analysis

Chapter 8: Market segmentation based on type applications

Chapter 9: Current and Future Trends

Request Customization as per your specific requirement@ https://www.emergenresearch.com/request-for-customization/1036

0 notes

writerblogs · 1 year ago

Text

Advancements Reshaping the Colonoscopy Devices Market

In the realm of medical diagnostics, the Colonoscopy Devices Market has emerged as a pivotal player, transforming the landscape of gastrointestinal health assessments. With the growing prevalence of colorectal diseases and the rising adoption of preventive healthcare, this market is undergoing rapid innovation, propelling it to new heights of efficacy and patient comfort.

The Colonoscopy Devices Market is witnessing a paradigm shift, fueled by technological advancements that are redefining the diagnostic experience. Traditional colonoscopy procedures were often met with anxiety and discomfort due to the invasive nature of the examination. However, modern colonoscopy devices are integrating high-definition imaging, ultra-slim designs, and advanced maneuverability, ensuring a less intrusive and more accurate assessment.

One of the groundbreaking trends in this market is the incorporation of artificial intelligence (AI) and machine learning. These technologies empower colonoscopists with real-time analysis and insights, enhancing the detection of polyps and abnormalities. AI-driven colonoscopy devices are poised to reduce human error, improve diagnostic accuracy, and ultimately save lives through early detection of colorectal diseases.

Moreover, the Colonoscopy Devices Market is experiencing a surge in the development of disposable and single-use colonoscopy devices. These innovative solutions eliminate the need for meticulous cleaning and sterilization processes, ensuring patient safety and reducing the risk of cross-contamination. As healthcare institutions prioritize infection control, these devices are gaining traction for their convenience and hygienic benefits.

Telemedicine is another pivotal trend shaping the Colonoscopy Devices Market. With the advent of remote medical consultations, patients can now undergo colonoscopy procedures while being remotely monitored by healthcare professionals. This approach not only enhances accessibility, especially in remote areas, but also minimizes the need for patients to travel long distances for screenings.

As patient comfort takes center stage, colonoscopy devices are being designed with features that alleviate discomfort and anxiety. Automated insertion and withdrawal technologies, along with advanced sedation techniques, are contributing to a more relaxed patient experience. These innovations are expected to drive higher participation rates in colorectal screenings, thereby leading to earlier disease detection.

In conclusion, the Colonoscopy Devices Market is on a transformative trajectory, fueled by technological innovations that prioritize accuracy, patient comfort, and convenience. The integration of AI, disposable devices, and telemedicine solutions are redefining the landscape of colonoscopy procedures, making them less invasive, more accurate, and accessible to a wider population. As the market continues to evolve, individuals can look forward to enhanced gastrointestinal health assessments that have the potential to revolutionize early disease detection and overall patient well-being.

#Colonoscopy devices #Gastrointestinal health #Medical diagnostics #Technological advancements #Minimally invasive procedures #AI-driven diagnostics #Telemedicine #Preventive healthcare #Colorectal cancer screening #Aging population #Remote patient monitoring #Market trends #Healthcare innovation #Medical Devices #Healthcare

0 notes

technuter · 2 years ago

Text

Airtel and Apollo Hospitals announced that they have carried out 5G driven, Artificial Intelligence (AI) guided Colonoscopy trial

Airtel and Apollo Hospitals announced that they have carried out India’s first 5G driven, Artificial Intelligence (AI) guided Colonoscopy trial. The trial was conducted using AI on Airtel’s 5G technology with ultra-low latency and high processing capabilities as a result of which the colon cancer got detected much faster and with greater accuracy. HealthNet Global, AWS and Avesha are the other three companies that collaborated in this trial. As a result of AI guided colonoscopy procedure, the image processing happened in real time without any lag even when the physician moved the scope through the colon for it to be overlaid on top of the right element of the colon. The advent of this technology enables an “extra pair of eyes” for physicians and improves the detection rate of polyps, thus saving lives and vastly improving patient care. The data was processed by Avesha edge inferencing applications on AWS platforms on a real time resulting in much faster analysis. AI assisted Colonoscopy Polyp Detection trial will help doctors to improve quality of patient care, improve accuracy of detection rates by capturing information correctly and reducing errors. 5G, Edge computing and Artificial Intelligence can significantly improve patient outcomes by assisting in proper and timely diagnoses. As per current protocol, colon cancer is detected through colonoscopy procedure which is manual and requires great attention and time from medical practitioners for accurate detection. Currently, the procedure is performed using a device comprising of flexible tube with light, camera and tools at one end, which are used to extract samples to identify an infected polyp. Not only is the procedure long, its discomforting for patients and for the doctors and nurses who perform the procedure which takes around 30 to 40 minutes. Speaking about the trial, Ajay Chitkara, CEO and Director, Airtel Business said “Ultra-fast, low latency 5G networks will transform the Healthcare sector in the country. At Airtel, we are geared up to lead this transformation and have demonstrated this by conducting India’s first colonoscopy trials. Healthcare is one of the most promising use cases for 5G, and we are delighted to collaborate Apollo Hospitals, AWS, HealthNet Global and Avesha. This is just the beginning, and I am certain we will bring many more innovative use cases that will help redefine healthcare in the country." Dr. Sangita Reddy, Joint Managing Director, Apollo Hospitals Group, said, “By augmenting doctor's ability to detect, AI has been proved to improve physician’s accuracy. Early detection and removal of polyps can easily avoid them becoming cancerous. Apollo has always been a fore runner in adoption of technology. Our patient centric approach keeps us on an outlook for technologies which can make outcomes better.” Vaishali Kasture, Head - Enterprise, Mid-Market & Global Businesses, India & South Asia – AWS India (Amazon Web Services India P Ltd) said “5G and edge technologies offer high speed and real-time data analysis that can help transform the delivery of healthcare. AI inference provides better insight and information to healthcare professionals to predict, diagnose, and treat patients more effectively. We are delighted to collaborate with Airtel and Apollo hospitals to bring AI-powered solutions with an aim to improve patient experience and healthcare service quality.” Colonoscopy procedures for early detection and prevention of cancers is being advised for all men and women above 45 years of age. In India, where the target population is large in terms of numbers, solutions built on 5G and AI are key to assist doctors to bring quality care to the maximum population Read the full article

0 notes

londongastrocare · 2 years ago

Text

Which is Best Gastro Clinic in Hyderabad

Gastroenterology is a branch of medicine that deals with digestive system disorders. London Gastro Care, the leading Gastro clinic in Kukkatpally , is a group of dedicated and experienced medical professionals who can provide the best solutions for all of your digestive system concerns.

London Gastro Care happens to be the best Gastro Clinic in Hyderabad. From the past two years, London Gastro Care is known to be the renowned and Best Gastro Care Clinic in Kukatpally. Dr Chandra Puli who has more than two decades of experience including international experience is the senior Best Gastroenterologist in Hyderabad .

The clinic has best-in-class equipment for advanced treatments, a pleasant atmosphere, a comfortable waiting area, and the doctor treats patients with dignity and care.

Services:

Colonoscopy: A colonoscopy is performed as an outpatient procedure. London Gastro Care is the best Gastro Clinic in Hyderabad for colonoscopies. Dr. Chandra Puli is one of the best. He has carried out numerous procedures in Hyderabad and London. A colonoscopy is a simple outpatient procedure that examines the inside of the large intestine (colon and rectum). A colonoscope is used during the examination (sometimes called a scope).

Early Cancer or Polyp Removal: Small growths on the inner lining of the colon (large bowel) or rectum are known as bowel polyps. They are widespread, affecting 15-20% of the UK population, and rarely cause symptoms. Polyps are typically less than 1cm in size, but they can grow to several centimetres in length.

Endoscopic Sleeve Gastroplasty: Endoscopic Sleeve Gastroplasty (ESG) is a microsurgical weight loss procedure in which an FDA-approved suturing device (OverstitchTM) is used to reduce stomach volume by 80%. This is accomplished through a series of hospital-placed endoscopy stitches through the stomach wall.

ERCP: ERCP is a procedure that examines your bile duct and pancreatic duct with an endoscope and X-rays. ERCP can also be used to remove gallstones or collect small tissue samples for analysis (a biopsy).

Endoscopic Ultrasound: An endoscopic ultrasound scan creates detailed images of internal organs and structures by using an endoscope with an ultrasound probe attached.

Gastroscopy: A gastroscopy is a procedure that uses a thin, flexible tube known as an endoscope to examine the oesophagus (gullet), stomach, and first part of the small intestine (duodenum).

Non-Surgical Weight Loss: The gastric balloon is the best nonsurgical weight loss procedure on the market. It is completely non-surgical and has a low impact on the body. The body has no incisions or small holes.

Liver Disease: Liver disease can be passed down through families (genetic). A variety of factors that damage the liver, such as viruses, alcohol use, and obesity, can also cause liver problems. Over time, conditions that damage the liver can lead to scarring (cirrhosis), which can lead to liver failure, a life-threatening condition. But early treatment may give the liver time to heal.

India has a large pool of well-trained medical professionals, which gives it a competitive advantage. India is also less expensive than its Asian and Western counterparts.The doctors here are really warm to the patients and ensure the procedures are conducted carefully. Best Gastro Clinic in Kukkatpally

The majority of germs that cause serious infections in humans are spread by humans. Good hand hygiene is one of the most effective ways to prevent these infections. According to several studies, healthcare providers clean their hands less than half of the time they should. As a result, healthcare-associated infections spread among hospitalised patients. At LGC, we ensure proper hygiene is maintained in the clinic in order to make our patients feel comfortable. Dealing with various people coming from different sections of the society, it is important for us to maintain good hygiene and make sure cleanliness is maintained.

For more information, feel free to connect with us at +91 8008528800

#gastro care hospital #gastric hospital hyderabad #gastro clinic in kukkatpally #Best gastro clinic in kukkatpally

0 notes

researchinhealthcare · 3 years ago

Text

Endoscopy Device Industry Drivers, Regional Analysis, Global Trends, Forecast to 2027

Endoscopy Device Market Overview :

The global endoscopy device market will grow at a CAGR of 6.30% during the forecast period 2019 to 2027. The market for endoscopy device is set to reach a higher valuation in the years to come.

As per endoscopy device market analysts, the global market is anticipated to witness growth owing to the factors such as increasing prevalence of chronic diseases as well as the development of endoscopy technologies.

However, the endoscopy device market will face challenges and restraints due to stringent regulatory policies and diseases and complications caused by endoscopy products during the forecast period 2019 to 2027. The growing incidence of chronic diseases in the endoscopy device market will support the growth. As per endoscopy device market analysts, the endoscopy device market based companies will face certain challenges during the 2019 to 2027.

The endoscopy device market research report provides in-depth analysis of the accessory & processors, application, end user, therapy, treatments & procedures, and types segments. The endoscopy device market research report presents factors such as increased costs associated with new product creation that could slow down the endoscopy device market's growth.

Endoscopy Device Market Segmentation :

The endoscopy device market has been segmented into accessory & processors, application, end user, therapy, treatments & procedures, and types . Based on the segment which is types, the market is categorized on the basis of capsule endoscopes, flexible endoscopes, rigid endoscopes, robot-assisted endoscopes, and surgical endoscopes. The global market for endoscopy device is further segmented based on therapy into arthroscopy, colonoscopy, cystoscopy, endoscopic retrograde cholangiopancreatography, gastroscopy, laparoscopy, sigmoidoscopy, and ureteroscopy.

Furthermore, the market, on the basis of treatments & procedures is segmented into lower gastrointestinal conditions, abdominal, gynecologic and pelvic organ conditions, joint and orthopedic conditions, lung and airway conditions, upper gastrointestinal conditions, and urinary system conditions. Based on applications the market is segmented into arthroscopy, bronchoscopy, gastrointestinal endoscopy, mediastinoscopy, obstetrics/gynecology endoscopy, otoscopy, and urology endoscopy.

The endoscopy device market based on accessory & processors is segmented into accessory and processors. Additionally, the market on the basis of technology is segmented into video and fiber.

The endoscopy device market report offers comprehensive study of the endoscopy device market segments including accessory & processors, application, end user, therapy, treatments & procedures, and types. The analysts have also studied the endoscopy device market's spread across the regional markets across many of the endoscopy device market’s segments at country levels. The accessory & processors, application, end user, therapy, treatments & procedures, and types segments spread across the endoscopy device market along with the subsegments are studied.

The global market for endoscopy device is spread across various product and service based segments. The endoscopy device market research report highlights these key segments and offers forecasts based on primary and secondary data. The global endoscopy device market research report presents key company profiles of organizations active across the endoscopy device market.

Click To Free Sample Report @ https://www.marketresearchfuture.com/sample_request/1967

Endoscopy Device Market Regional Overview :

Service offerings to consumers may hinder the endoscopy device market growth. The endoscopy device market research report suggests that companies in the endoscopy device market could be supported by expanded support and coverage for endoscopic screening and care as well as the rising geriatric population around the world during the forecast period.

The endoscopy device market is set to register growth at a high CAGR owing to these key factors. The endoscopy device market is spread across North America, Europe, Asia-Pacific, and other parts of the world. As per endoscopy device market analysts, the endoscopy device market is set to witness tremendous growth across accessory & processors, application, end user, therapy, treatments & procedures, and types segments.

The global endoscopy device market’s North American region covers endoscopy device markets across the United States, Mexico, Canada, and others. Businesses present in the endoscopy device market are also profiled and their strategies have been presented in detail in the endoscopy device market research report. The endoscopy device market across the European region covers Italy, France, Germany, and the United Kingdom.

Furthermore, the endoscopy device market research report provides details about the APAC region covering endoscopy device markets from China, India, Australia, Japan, and others. The endoscopy device market is also active across several other parts of the world. The endoscopy device market report covers all these key regions including the Middle East, Africa, Brazil, and others active in the global endoscopy device market..

Endoscopy Device Market Competitive Landscape :

Endoscopy devices have seen tremendous growth, due to increased preference for minimally invasive and the growing success of minimally invasive surgery. However, loss of sales due to the delay in release of the product and strict approval procedures would challenge the companies active in the endoscopy device market. Furthermore, companies using growth strategies to stay ahead in the global endoscopy device market are expected to help the market during the forecast period 2019 to 2027.

As the endoscopy device market report suggests that the endoscopy device market will register a CAGR of 6.30% and reach a greater valuation in the coming years, the market report highlights key areas endoscopy device market based companies need to focus on. The endoscopy device market research report projects a long term growth till 2027.

Based on endoscopy device market’s analysis on the basis of SWOT and Porters’ Five Force Model, the endoscopy device market will rise during the forecast period 2019 to 2027, however the companies need to move ahead with caution. The endoscopy device market research report highlights such key areas.

Endoscopy Device Market News :

The Japanese medtech giant Olympus reported that it has entered into an agreement to purchase up to 50 million € of Quest Photonic Devices to expand its operative endoscopy presence. The net purchase price includes landmark fees. Quest is developing advanced FIS systems that allow more chirurgical endoscopy than current technologies.

FIS applies to light imaging methods using fluorescent colouring to visualise such anatomical structures. This targeted teeth, along with some light wavelengths, allow to see almost invisible tissues or lesions in standard white light. Access Complete Report @ https://www.marketresearchfuture.com/reports/endoscopy-devices-market-1967

#Endoscopy Device Market Share #Endoscopy Device Market Size #Endoscopy Device Market Trends #Endoscopy Device Market Overview

1 note · View note

manideep8 · 2 years ago

Text

Cancer Testing/Screening Market - Forecast (2022 - 2027)

Cancer Testing Screening Market Report Coverage

The report: “Cancer Testing Screening Market Forecast (2022-2027)”, by Industry ARC, covers an in-depth analysis of the following segments of the Cancer Testing Screening Market.

Inquiry Before Buying : https://www.industryarc.com/reports/request-quote?id=15062

Key Takeaways

Request For Sample : https://www.industryarc.com/pdfdownload.php?id=15062

Cancer Testing Screening Market Segment Analysis – By Cancer Type

Cancer Testing Screening Market Segment Analysis – By Technique

Cancer Testing Screening Market Segment Analysis – By Geography

Cancer Testing Screening Market Drivers

Growing Number Of Cancer Screening Awareness Campaigns To Raise Awareness About The Importance Of Early Detection Of Breast Cancer Is To Drive Market Growth

Technological Advancements And Automation In Cancer Testing And Screening Is To Fuel Service Demand

Cancer Testing Screening Market Challenges

High Cost Of Cancer Diagnosis And Increased Financial Burden To Hamper The Market Growth

Buy Now : https://www.industryarc.com/purchasereport.php?id=15062

Cancer Testing Screening Industry Outlook

DiaSorin S.p.A

Immunodiagnostic Systems Holdings Ltd

Epigenomics AG

Quest Diagnostics Inc.

F. Hoffmann-La Roche Ltd

VolitionRX Limited

Abbott Laboratories

QIAGEN GmbH

Siemens Healthineers AG

Becton, Dickinson, and Company

Recent Developments

Relevant Titles:

Cancer Biomarkers Market Forecast (2022-2027)

Report Code: HCR 0194

Cancer Diagnostics Market - Forecast(2022 - 2027)

Report Code: HCR 0195

Oncology Clinical Trials Market - Forecast(2022 - 2027)

Report Code: HCR 1377 For more Lifesciences and Healthcare related reports, please click here

#cancer #testing #screening #Biopsy #Diagnostics

0 notes

industryinsights · 3 years ago

Text

Capsule Endoscopy Market Size, Key Players, SWOT, Revenue Growth Analysis Till 2027

Capsule endoscopy is the part of endoscopy in which a small capsule and pill shaped wireless camera used to examine the digestive system. It is the advanced step up of endoscopy. This method is used to identify diseases like gastrointestinal bleeding, oesophageal diseases, intestine diseases and colon related diseases. Increasing prevalence of these diseases are the major driving factor for the market. Continuous technological advancement in endoscopy and increasing healthcare spending has provided fuel for the growth of the market. But high cost for the diagnosis and limited reimbursement are the major hurdles for the growth of the Capsule endoscopy market.

Further an endoscopy is a procedure that allows physicians or surgeons to look inside interior parts of the organ. The technique is used for both diagnostic and therapeutic purpose. To perform endoscopy a specialized instrument is used named as endoscope. There are various type of endoscopes and adoption of endoscope depends upon the affected body organ such as, bronchoscopes are used for lungs related problem, arthroscopes are preferred for problems associated with joints, and many others. Other instruments required during an endoscopic procedure includes Biopsy forceps, Cytology brush, Flexible forceps, trocar sleeves, etc. For therapeutic purpose, endoscopes are either attached or passed through surgical instruments to perform particular surgery. Endoscopic Surgery is a type of minimally invasive surgery in which an endoscope is inserted in the body through small incisions to examine the internal organs. The major advantages associated with endoscopic surgery are small incisions, minimal blood loss, less scarring, low risk of infection, and less recovery time. As per the 2014 statistics suggested by Eurostat, it is observed that the Cataract surgery is the most common minimally invasive surgery in the European region as this surgery was performed 4.3 million times across the EU Member States and another most commonly used procedure was bronchoscopy for diagnosis with a frequency rate of 685 per 100 000 inhabitants in Croatia and more than 400 in Latvia and Germany.

Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/1359

Rising prevalence rate of chronic diseases, technological advancement in endoscopy, and increasing funding and reimbursement towards screening and treatment with endoscopic techniques are promoting the growth of endoscopy devices market globally increasing popularity of minimally invasive surgery is also creating a huge scope for the growth of market.

Despite these drivers, there are some issues associated with endoscopy devices market. Lack of skilled physicians and endoscopists, and infections caused by endoscopes may hinder the growth of market to an extent.

Fujifilm Holding Corporation (Japan), Olympus Corporation (Japan), Given Imaging (Israel), RF System Lab (US), Capso Vision Inc. (US), IntroMedic Co., Ltd. (South Korea), Chongqing Jinshan Science & Technology Co. (China), Johnson and Johnson (US) and others are some of the major players in the Global Capsule endoscopy Market.

Global Capsule endoscopy Market – Regional Analysis

Geographically, Americas region is commanding the largest market share owing to the increasing adoption rate of endoscopic surgery. According to the Centers for Disease Control and Prevention, it is reported that in the United States due to increase in colonoscopy procedures the percentage of population detected with colon cancer has been increased. It is also estimated that on considering colonoscopy screening capacity of the United States now, 80% of the eligible population will be screened by 2023

Further Thus the market potential of nations such as India, Thailand, Vietnam etc. is huge which has been constrained by lack of healthcare professionals specifically endoscopists.

The market maturity of different nations also varies by an immense scale. China has the most market potential followed by India. India represents the next nation which will drive the future capsule endoscopy device market. Developed markets such as Japan, US etc. is likely to witness modest low single digit growth. The competition is also strong in the developed regions market. Thus developing region nations such as India, Argentina etc. are ideal for any new entrant.

There were approximately 15,000,000 endoscopy procedures in the US in 2016 alone. The population of US in 2016 is approximately 323.1 million. Thus there is one endoscopy procedure performed per 20 million population. The comparative rates for developing regions are far below taking the United States as reference base. Hence it is estimated that the market potential for global capsule endoscopy is expected to huge and will grow immensely in the coming future.

Browse Full Report @ https://www.marketresearchfuture.com/reports/capsule-endoscopy-market-1359

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Have a Look at Related Reports:

Telehealth Market

Implantable Cardioverter Defibrillator Market

Cardiomyopathy Medication Market

Onychomycosis Market

Liver Cirrhosis Treatment Market

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 628 258 0071

Email: [email protected]

0 notes

globalaircraft · 3 years ago

Text

Global Colonoscopes Market Trend

Global Colonoscopes Market will exhibit a CAGR of 4.8% for the forecast period of 2021-2028

Market Analysis and Insights: Colonoscopes Market

Colonoscopy is a type of endoscopic examination procedure of the distal part of the small bowel and the large intestine by a fiber optic camera on a flexible tube that is passed through the anus or a charge-coupled device (CCD) camera. Colonoscopy is mostly used for screening of colorectal cancer. A colonoscopy helps to find tumors, ulcers, colon polyps, tumors and other areas of bleeding or inflammation. The colonoscope is a flexible and thin tube, within the range of 125 cm-183 cm long size. A video camera is fixed at the tip of the colonoscopy devices so that the physician can take and see video or pictures of the colon.

Increasing guidelines from healthcare organizations are the main driving factor for the colonoscopes market. The growing awareness of the effects of disorders of the colon is also a driving factor for the colonoscopes market. Intense technological advancements and growing research activities to extend its applications in therapeutic areas and the development of robotic colonoscopes is an opportunity for the colonoscopes market.

Colonoscopes market research report has been organized with most up-to-date insight and analysis to give maximum benefits to the healthcare industry. The report can be used by both established and new players in the industry for complete understanding of the market. Besides, this business report also includes historic data, present and future market trends, environment, technological innovation, upcoming technologies and the technical progress in the related industry. The scope of this colonoscopes market analysis report involves industry research, customer insights, market sizing and forecast, competitive analysis, market entry strategy, pricing trends, sustainability trends, innovation trends, technology evolution, and distribution channel assessment.

Global Colonoscopes Market Scope and Market Size:

Based on product type, the colonoscopes market is segmented into fiber optic colonoscopy devices and video colonoscopy devices.

Based on technology, the colonoscopes market is segmented into instruments and accessories and colonoscopy devices service.

Based on end-user, the colonoscopes market is segmented into hospitals, ambulatory surgery centres and others.

Global Colonoscopes Market Country Level Analysis:

The countries covered in the Colonoscopes market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Get Sample Report here: https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-colonoscopes-market

Get full report: https://www.databridgemarketresearch.com/reports/global-colonoscopes-market

Major TOC of the Report:

Chapter One: Introduction

Chapter Two: Market Segmentation

Chapter Three: Market Overview

Chapter Four: Executive Summary

Chapter Five: Premium Insight

Chapter Six: COVID-19 Impact on Global Colonoscopes Market

Get TOC here: https://www.databridgemarketresearch.com/toc/?dbmr=global-colonoscopes-market

Competitive Landscape & Colonoscopes Share Analysis:

The Colonoscopes market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, regional presence, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies�� focus related to Colonoscopes market.

All the data, statistics, and information collected in the report has been studied and analyzed with the demonstrated tools and techniques such as SWOT analysis and Porter's Five Forces analysis. The report provides a profound overview of product specification, technology, and product type and production analysis considering major factors such as revenue, cost, and gross margin. Colonoscopes market document acts upon systematic gathering, recording and analysis of data for the concerns linked to the marketing of goods and services and thereby serve the healthcare industry with an excellent market research report. Granular market information assembled in this Colonoscopes report will be helpful to healthcare industry to take competent business decisions.

Key Players:

FUJIFILM Holdings Corporation

Karl Storz

Olympus Corporation

Endomed Systems

Boston Scientific

Avantis, HOYA Corporation

Getinge AB

About Us:

Contact:

Data Bridge Market Research

Tel: +1-888-387-2818

Email: [email protected]

#Colonoscopes Market Trend

0 notes

vicky8588 · 3 years ago

Text

Local Anesthesia Drugs Market

Market Overview

The global local anesthesia drugs market size was valued at US$ XX billion in 2020 and is estimated to reach US$ XX billion by 2028, growing at a CAGR of XX % during the forecast period (2021-2028).

Local anesthesia is the temporary loss of sensation in a particular body part or localized areas. Local anesthesia drugs are given in order to treat the painful situations for the elimination of pain while performing any major or some minor surgeries, or also to eliminate pain post-surgery.

Download Free Samples @ https://www.datamintelligence.com/download-sample/local-anesthesia-drugs-market

Market Dynamics

The surge in cases drives the global-local anesthesia drugs market growth to perform surgeries and improve drug delivery. Computer-based local anesthetic delivery and vibrotactile devices are estimated to boost the global-local anesthesia drugs market's forecast period.

The increase in the number of surgeries is expected to drive growth in the forecast period

Anesthesia is one of the essential components of any surgical procedure. It induces temporary unconsciousness and loss of protective reflexes. According to the Centers for Disease Control and Prevention (CDC), more than 51 million inpatient surgeries and 53 million outpatient surgeries were performed in the United States in 2017. Cardiology, surgical, and obstetrical procedures were the most common ones. In Europe, many surgeries are being performed for cases of cataracts, tonsillectomy, colonoscopy, cesarean sections, and hip replacements. Besides, several procedures, such as cochlear implantation, laparoscopic colectomy, laparoscopic hysterectomy, secondary hip replacement, and knee replacement, have become more frequent in recent years. Hence, the overall increase in the number of surgeries performed has a strong impact on the anesthetic drug market. These drugs are used in all surgical procedures to reduce pain during surgery.

Rising prevalence of cardiovascular and respiratory system-related diseases expected to drive the market growth

Factors such as the rapid rise in the aging population, rising prevalence of cardiovascular and respiratory system-related diseases are key factors driving the market's growth. The state allows surgical operations and other medical processes to be carried out on patients without causing them undue distress or discomfort. Surgical operations of the eyes are performed using a wide variety of anesthetic techniques. Advancements in drug delivery technologies are also expected to contribute to the demand for local anesthetics in surgical procedures. For instance, DepoFoam technology uses a new method to deliver bupivacaine and is very efficient in managing post-operative pain. The market growth for local anesthesia drugs is also fueled by introducing new and effective drugs such as articaine, levobupivacaine, and ropivacaine. This growth is supplemented by increasing healthcare expenditure in developing countries such as India, China, and Brazil, where the number of surgeries performed has been on a steady rise. These factors are driving the growth of the market in the forecast period.

The major side effects of drugs are likely to hinder market growth.

However, some major side effects of drugs, such as cardiovascular toxicity, CNS toxicity, and respiratory depression, are among the significant factors that pull back the market to achieve its full potential in the global-local anesthesia drugs market.

COVID-19 Impact Analysis

Several quick changes in response to COVID-19 have had an immediate impact on local anesthesia drugs and their practices. While some of the disruptions are temporary, others will persist over the longer term. Economic shocks are already evident for the supply chain and anesthesia workforce, and some temporary shocks may return with anticipated future waves of COVID-19. The first and most challenging impacts are due to the canceling or postponement of non-essential surgical procedures. This reduction has a direct negative financial impact on anesthesiology practices and can lead to workforce reductions for practices that specialize in these types of procedures. Different anesthesia methods may be required to reduce medications use to support patients on ventilators for procedures that are still being performed. Nerve blocks and local anesthesia are other options that can be considered. Another disruption is the surging demand for non-essential procedures that have been delayed by the pandemic. Once the pandemic wanes, procedures that have been postponed will need to be rescheduled along with others. This will lead to an increased demand for the local anesthesia drugs market.

Segment Analysis

The bupivacaine segment is expected to grow at the fastest CAGR during the forecast period (2021-2028)

Bupivacaine is a local anesthetic drug that has been used in various surgical procedures. This is helpful in blocking the nerve impulses that send pain signals to the brain. As per the Royal College of Surgeons, in England (U.K), there were around 4.7 million surgical admissions in 2013/14. There has been a 27% increase in the number of admissions for surgical procedures between 2003-2004 and 2013-14. The most common surgical procedures are hernia repairs, hip replacement, knee replacement, gall bladder removal, and tonsillectomies.

Bupivacaine is widely used as local anesthesia, due to its efficacy in numbing certain organ. Hence, the rising number of surgeries leads to high demand for local anesthesia drugs and is expected to propel the growth of the market.

The hospital pharmacy is expected to dominate the Local Anesthesia drugs market during the forecast period.

The hospital pharmacies held the largest share in the local anesthesia drugs market. This is mainly due to the increasing number of patients suffering from conditions treated in hospitals equipped with advanced infrastructure and adequate facilities. Moreover, the growing number of hospitals and adequate reimbursement policies are also contributing to the growth of this segment.

Geographical Analysis

North America region holds the largest market share global local anesthesia drugs market

North America region is dominating the global-local anesthesia drugs market accounted for the largest market share in 2020. The US anesthesia market is the largest regional market in the world. The market is mainly driven by factors, such as the increasing number of surgeries, rising aging population with increasing chronic conditions, and advancements in anesthesia technologies. Due to the rising scope of local anesthesia in the market, key players are making efforts to develop novel and innovative drugs, thus fueling the market growth in the region

View Full Report @ https://www.datamintelligence.com/research-report/local-anesthesia-drugs-market

Competitive Landscape

The local anesthesia drugs market is moderately competitive with presence of local as well as global companies. Some of the key players which are contributing to the growth of the market include Fresenius Kabi USA, LLC, Pfizer Inc., Advanced Pharma, Inc., Akorn, Inc. Teva Pharmaceutical Industries Ltd., Akorn, Inc., Glenmark Pharmaceuticals, Inc., Baxter international, Inc., and Novartis AG., among others. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the local anesthesia drugs market globally.

Local Anesthesia Drugs Market Key Companies to Watch

Pfizer Inc.

Overview: Pfizer Inc. (Pfizer), incorporated on June 2, 1942, is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development and manufacture of healthcare products. Its global portfolio includes medicines and vaccines. The Company manages its commercial operations through two business segments: Pfizer Innovative Health (IH) and Pfizer Essential Health (EH). IH focuses on developing and commercializing medicines and vaccines that improve patients' lives. IH therapeutic areas include internal medicine, vaccines, oncology, inflammation and immunology and rare diseases. EH includes legacy brands, branded generics, generic sterile injectable products, biosimilars and infusion systems. EH also includes a research and development (R&D) organization, as well as its contract manufacturing business. The Company sold its products in over 125 countries.

Product Portfolio: The Company’s portfolio comprised of includes internal medicine, vaccines, oncology, inflammation and immunology and rare diseases and others.

For Enquiry @ https://www.datamintelligence.com/enquiry/local-anesthesia-drugs-market

About Us

DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year, we have secured more than 100 unique customers from established organizations all over the world.

For more information:

Sai Kiran

Sales Manager at DataM Intelligence

Email: [email protected]

Tel: +1 877 441 4866

Website: www.datamintelligence.com

#bupivacaine #lidocaine #benzocaine #Ropivacaine

0 notes

newsresearch · 3 years ago

Text

Colonoscopes Market Astonishing Growth with Top Influencing Key players

Colonoscopes market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the colonoscopes market to grow at a CAGR of 4.8% in the above-mentioned forecast period.

Key Market Competitors: Global Colonoscopes Market

Few of the major competitors currently working in the colonoscopes market are FUJIFILM Holdings Corporation, Karl Storz , Olympus Corporation, Endomed Systems, , Boston Scientific, Avantis, , HOYA Corporation. ,Getinge AB., SonoScape Medical Corp., Endo Technologies,, Smart Medical Systems Ltd, GI-View.,Steris, among others.

Download exclusive PDF sample report@ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-colonoscopes-market

Colonoscopy helps to find tumors, ulcers, colon polyps, tumors and other areas of bleeding or inflammation. The colonoscope is a flexible and thin tube, within the range of 125 cm-183 cm long size. A video camera is fixed at the tip of the colonoscopy devices, so that the physician can take and see video or pictures of the colon.

Segmentation: Global Colonoscopes Market

· By Product Type (Fiber Optic Colonoscopy Devices, Video Colonoscopy Devices)

· By Technology (Instruments and Accessories, Colonoscopy Devices Service)

· By End-User (Hospitals, Ambulatory surgery centers, others)

· By Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa)

Competitive Analysis: Global Colonoscopes Market

Global colonoscopes market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of Albumin Market for global, Europe, North America, Asia Pacific, South America and Middle East & Africa.

Market Drivers:

· Increasing guidelines from healthcare organizations is expected to drive the market growth

· The growing awareness of the effects of disorders of the colon is also expected to drive the market growth

Market Restraints:

· The risks associated with colonoscopy is expected to restrain the market growth

· Lack of skilled healthcare professionals for colonoscopy is also expected to restrain the market growth

Reasons to Purchase this Report:

· Current and future of global colonoscopes market outlook in the developed and emerging markets

· The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period

· Regions/Countries that are expected to witness the fastest growth rates during the forecast period

· The latest developments, market shares, and strategies that are employed by the major market players

Inquiry Before Buying @ https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-colonoscopes-market

Customization of the Report:

· All segmentation provided above in this report is represented at country level

· All products covered in the market, product volume and average selling prices will be included as customizable options which may incur no or minimal additional cost (depends on customization)

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge Market Research provides appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:

Data Bridge Market Research

US: +1 888 387 2818

Related Reports:

Pregnancy Care Products Market

Pulse Dye Laser Market

#Colonoscopes Market #Colonoscopes #Colonoscopes Market trends #Colonoscopes Market Industry #Colonoscopes Market news #Colonoscopes Market Research

0 notes